Volume: 26 Issue: 6

Michel G Bergeron ?MGB? ? a true success Digging for new solutions Invasive disease due to Haemophilus influenzae type A in children in Canada?s north: A priority for prevention. Letter to the Editor: Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients An unusual case of abdominal pain Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A)<span style="font-style: italic">Neisseria meningitidis</span> can cause several invasive diseases. Serogroup distribution has been known to be related to geographical differences and, in Canada, most invasive meningococcal disease cases have been caused by serogroups B (MenB) and C. Following the introduction of a meningitis C vaccine, most cases are now caused by MenB. Characterization of invasive meningococcal disease case isolates from Atlantic Canada provides a snap shot of the molecular epidemiology, shedding light on the future of a MenB vaccine. Fidaxomicin: A novel agent for the treatment of Clostridium difficile infectionOral vancomycin and oral metronidazole have several limitations with regard to their use in the treatment of <span style="font-style: italic">Clostridium difficile </span>infections (CDIs); howeve...
Source: Canadian Journal of Infectious Diseases and Medical Microbiology - Category: Infectious Diseases Source Type: research